357 related articles for article (PubMed ID: 33308315)
1. Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma.
Li M; Li G; Kiyokawa J; Tirmizi Z; Richardson LG; Ning J; Das S; Martuza RL; Stemmer-Rachamimov A; Rabkin SD; Wakimoto H
Acta Neuropathol Commun; 2020 Dec; 8(1):221. PubMed ID: 33308315
[TBL] [Abstract][Full Text] [Related]
2. FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors.
Cremasco V; Astarita JL; Grauel AL; Keerthivasan S; MacIsaac K; Woodruff MC; Wu M; Spel L; Santoro S; Amoozgar Z; Laszewski T; Migoni SC; Knoblich K; Fletcher AL; LaFleur M; Wucherpfennig KW; Pure E; Dranoff G; Carroll MC; Turley SJ
Cancer Immunol Res; 2018 Dec; 6(12):1472-1485. PubMed ID: 30266714
[TBL] [Abstract][Full Text] [Related]
3. Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors.
Shi Y; Kong Z; Liu P; Hou G; Wu J; Ma W; Cheng X; Wang Y
Cells; 2021 May; 10(5):. PubMed ID: 34068501
[TBL] [Abstract][Full Text] [Related]
4. Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager.
de Sostoa J; Fajardo CA; Moreno R; Ramos MD; Farrera-Sal M; Alemany R
J Immunother Cancer; 2019 Jan; 7(1):19. PubMed ID: 30683154
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.
Krepela E; Vanickova Z; Hrabal P; Zubal M; Chmielova B; Balaziova E; Vymola P; Matrasova I; Busek P; Sedo A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494271
[TBL] [Abstract][Full Text] [Related]
7. Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer.
Jing Y; Chavez V; Ban Y; Acquavella N; El-Ashry D; Pronin A; Chen X; Merchan JR
Mol Cancer Res; 2017 Oct; 15(10):1410-1420. PubMed ID: 28679779
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.
van den Bossche WBL; Kleijn A; Teunissen CE; Voerman JSA; Teodosio C; Noske DP; van Dongen JJM; Dirven CMF; Lamfers MLM
Neuro Oncol; 2018 Oct; 20(11):1494-1504. PubMed ID: 29796615
[TBL] [Abstract][Full Text] [Related]
10. Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma.
Kiyokawa J; Kawamura Y; Ghouse SM; Acar S; Barçın E; Martínez-Quintanilla J; Martuza RL; Alemany R; Rabkin SD; Shah K; Wakimoto H
Clin Cancer Res; 2021 Feb; 27(3):889-902. PubMed ID: 33257429
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.
Saha D; Wakimoto H; Peters CW; Antoszczyk SJ; Rabkin SD; Martuza RL
Clin Cancer Res; 2018 Jul; 24(14):3409-3422. PubMed ID: 29599413
[No Abstract] [Full Text] [Related]
12. TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α.
Huang M; Fu M; Wang J; Xia C; Zhang H; Xiong Y; He J; Liu J; Liu B; Pan S; Liu F
Biochem Pharmacol; 2021 Jun; 188():114527. PubMed ID: 33741330
[TBL] [Abstract][Full Text] [Related]
13. Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents.
Roy J; Hettiarachchi SU; Kaake M; Mukkamala R; Low PS
Theranostics; 2020; 10(13):5778-5789. PubMed ID: 32483418
[No Abstract] [Full Text] [Related]
14. STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy.
Arwert EN; Milford EL; Rullan A; Derzsi S; Hooper S; Kato T; Mansfield D; Melcher A; Harrington KJ; Sahai E
Nat Cell Biol; 2020 Jul; 22(7):758-766. PubMed ID: 32483388
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity.
Akai M; Noma K; Kato T; Nishimura S; Matsumoto H; Kawasaki K; Kunitomo T; Kobayashi T; Nishiwaki N; Kashima H; Kikuchi S; Ohara T; Tazawa H; Choyke PL; Kobayashi H; Fujiwara T
Br J Cancer; 2024 Jun; 130(10):1647-1658. PubMed ID: 38555315
[TBL] [Abstract][Full Text] [Related]
16. Endogenous brain pericytes are widely activated and contribute to mouse glioma microvasculature.
Svensson A; Özen I; Genové G; Paul G; Bengzon J
PLoS One; 2015; 10(4):e0123553. PubMed ID: 25875288
[TBL] [Abstract][Full Text] [Related]
17. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
Yang X; Lin Y; Shi Y; Li B; Liu W; Yin W; Dang Y; Chu Y; Fan J; He R
Cancer Res; 2016 Jul; 76(14):4124-35. PubMed ID: 27216177
[TBL] [Abstract][Full Text] [Related]
18. Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma.
Galbo PM; Madsen AT; Liu Y; Peng M; Wei Y; Ciesielski MJ; Fenstermaker RA; Graff S; Montagna C; Segall JE; Sidoli S; Zang X; Zheng D
Clin Cancer Res; 2024 Feb; 30(4):865-876. PubMed ID: 38060213
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features.
Pellinen T; Paavolainen L; Martín-Bernabé A; Papatella Araujo R; Strell C; Mezheyeuski A; Backman M; La Fleur L; Brück O; Sjölund J; Holmberg E; Välimäki K; Brunnström H; Botling J; Moreno-Ruiz P; Kallioniemi O; Micke P; Östman A
J Natl Cancer Inst; 2023 Jan; 115(1):71-82. PubMed ID: 36083003
[TBL] [Abstract][Full Text] [Related]
20. Fiber-modified hexon-chimeric oncolytic adenovirus targeting cancer associated fibroblasts inhibits tumor growth in gastric carcinoma.
Pang T; Wang X; Gao J; Chen W; Shen XJ; Nie MM; Luo T; Yin K; Fang G; Wang KX; Xue XC
Oncotarget; 2017 Sep; 8(44):76468-76478. PubMed ID: 29100326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
